Johnson & Johnson in Ireland is rebranding its pharmaceutical segment to Johnson & Johnson Innovative Medicine and its medical technology segment to Johnson & Johnson MedTech. With a workforce of over 6,000 people, the company aims to leverage its expertise in innovative medicine and medical technology to address complex diseases. The rebranding is part of a global rollout of the new Johnson & Johnson brand, which aims to showcase healthcare innovation in an inclusive manner. The goal remains unchanged: to innovate with purpose and lead the way in medicine. The company’s Irish operations make a significant contribution to its global success.
Source link
Janssen to adopt Johnson & Johnson brand in Ireland
